These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3447909)

  • 21. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats.
    Um SY; Chung MW; Kim KB; Kim SH; Oh JS; Oh HY; Lee HJ; Choi KH
    Anal Chem; 2009 Jun; 81(12):4734-41. PubMed ID: 19462990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
    Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
    Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
    Rybár I; Kriska M; Vavrecka A; Hyrdel R; Rovenský J
    Cas Lek Cesk; 1999 Nov; 138(22):675-80. PubMed ID: 10746025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
    Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs.
    Wolfe MM
    Int J Clin Pract Suppl; 2003 Apr; (135):32-7. PubMed ID: 12723745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indomethacin fails to induce ulceration in the gastrointestinal tract of newborn and suckling rats.
    Bedrick AD; Holtzapple PG
    Pediatr Res; 1986 Jul; 20(7):598-601. PubMed ID: 3725456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
    Zhong ZY; Sun BB; Shu N; Xie QS; Tang XG; Ling ZL; Wang F; Zhao KJ; Xu P; Zhang M; Li Y; Chen Y; Liu L; Xia LZ; Liu XD
    Acta Pharmacol Sin; 2016 Jul; 37(7):1002-12. PubMed ID: 27180979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved.
    Beck WS; Schneider HT; Dietzel K; Nuernberg B; Brune K
    Arch Toxicol; 1990; 64(3):210-7. PubMed ID: 2115324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diets with no or low amounts of dietary fiber can reduce small intestinal ulcers induced by non-steroidal anti-inflammatory drugs in dogs.
    Satoh H; Kondo R; Shinoda T; Idaka S; Ishigami K; Shiotani S
    J Physiol Pharmacol; 2016 Aug; 67(4):563-573. PubMed ID: 27779477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats.
    Atchison CR; West AB; Balakumaran A; Hargus SJ; Pohl LR; Daiker DH; Aronson JF; Hoffmann WE; Shipp BK; Treinen-Moslen M
    Gastroenterology; 2000 Dec; 119(6):1537-47. PubMed ID: 11113075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards safer nonsteroidal anti-inflammatory drugs.
    Brune K; Beck WS
    Agents Actions Suppl; 1991; 32():13-25. PubMed ID: 2069081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the indomethacin-induced intestinal lesions in the rat.
    Mariani L
    Eur J Toxicol Environ Hyg; 1975; 8(6):335-9. PubMed ID: 1204671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.
    Reuter BK; Davies NM; Wallace JL
    Gastroenterology; 1997 Jan; 112(1):109-17. PubMed ID: 8978349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat.
    Zahavi I; Fisher S; Marcus H; Heckelman B; Kiro A; Dinari G
    J Pediatr Gastroenterol Nutr; 1995 Aug; 21(2):154-7. PubMed ID: 7472901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.
    Dalby AB; Frank DN; St Amand AL; Bendele AM; Pace NR
    Appl Environ Microbiol; 2006 Oct; 72(10):6707-15. PubMed ID: 17021222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem.
    Bjarnason I; Macpherson A
    Scand J Gastroenterol Suppl; 1989; 163():56-64. PubMed ID: 2683029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.